*February 2022*
View the video or read the transcript of expert perspectives on the management of C797S-mutated non–small cell lung cancer following failure of frontline TKIs.
*February 2022*
View the video or read the transcript of expert perspectives on the management of C797S-mutated non–small cell lung cancer following failure of frontline TKIs.





The EGFR Resisters is a global community of patients and caregivers impacted by EGFR-positive lung cancer. We’re here to share knowledge, offer support and collaborate to drive progress in research and care. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.
